. Author manuscript; available in PMC: 2014 Oct 16.

Published in final edited form as: Int J Radiat Oncol Biol Phys. 2012 Nov 22;85(5):1206–1211. doi: 10.1016/j.ijrobp.2012.10.008

Table 3. Overall Survival by 0211 (per protocol/acceptable) vs. historical control.

The median OS for patients treated on RTOG 0211 per protocol or with acceptable deviation was 11.5 months versus 11.0 months for historical controls treated by RT alone (HR (0211 v. historical control) = 1.14; 95%CI: 0.94 – 1.37; p (one-sided) = 0.91). Median OS for all eligible patients was 11.1 months.

Months	0211 Per protocol/Acceptable		Historical control
Months	Survival	# at Risk	Survival	# at Risk
0	100%	119	100%	1457
3	97%	115	90%	1315
6	78%	93	77%	1115
9	65%	77	61%	890
12	45%	54	44%	640
15	26%	31	32%	458
18	19%	23	23%	328
24	9%	10	13%	188

Median Survival Time (MST)	11.5 months		11.0 months
Dead/Total	117/119		1405/1457
Hazard ratio (λ₀₂₁₁/λ_historical) (95% CI)	1.14 (0.94 to 1.37)
p-value(one-sided log rank)	0.91